Skip to main content
Figure 1 | Critical Care

Figure 1

From: Evaluation of urinary tissue inhibitor of metalloproteinase-2 in acute kidney injury: a prospective observational study

Figure 1

Biomarker values grouped by acute kidney injury severity. Values of the evaluated biomarkers measured at intensive care unit admission are shown in each acute kidney injury (AKI) severity category (non-AKI (n = 56), stage 1 (n = 15), stage 2 (n = 7), stage 3 (n = 20)). *P < 0.05. Cre, Creatinine; EPO, Erythropoietin; IL-6, Interleukin-6; NAG, N-acetyl-β-d-glucosaminidase; NGAL, Neutrophil gelatinase-associated lipocalin; TIMP-2, Tissue inhibitor of matrix metalloproteinase-2.

Back to article page

Critical Care

ISSN: 1364-8535